News 08 Mar 2021 Debiopharm enters EUR 900+ million contract with Merck Debiopharm has granted a worldwide exclusive license to pharma giant Merck for the development and commercialization of its Xevinapant head and n...
News 13 Lug 2021 Merck reaches key milestone in the construction of its Biotech Development Center Merck has celebrated the completion of the structural work on its Biotech Development Center currently under construction in Corsier-sur-Vevey.